Načítá se...
Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting
The current standard of care treatment for severe hemophilia A and B (SHA and SHB) is the prophylactic intravenous replacement of coagulation factor VIII or IX (FVIII/FIX) to prevent spontaneous bleeding. Persons with hemophilia without prophylactic treatment receive therapy in case of bleeding, i.e...
Uloženo v:
| Vydáno v: | Ann Hematol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7683481/ https://ncbi.nlm.nih.gov/pubmed/32918114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04250-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|